Processa Pharmaceuticals Inc. reconvened its Annual Shareholder Meeting on July 30, 2025. The proposals presented during the meeting included the election of board members and the ratification of the appointment of the independent registered public accounting firm. The election of board members was approved, as was the ratification of the appointment of the accounting firm.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-017185), on June 30, 2025, and is solely responsible for the information contained therein.